Personalis to Present at the Morgan Stanley 20th Annual Global Healthcare ConferenceBusiness Wire • 08/30/22
Personalis Adds New MRD Patent Covering the Combination of Tumor-Informed and Database-Derived Content to Patent Infringement Complaint Against Foresight DiagnosticsBusiness Wire • 08/17/22
Personalis in Partnership with BC Cancer to Assess Clinical and Economic Benefits of ctDNA for Colorectal and Pancreatic CancersBusiness Wire • 08/15/22
Personalis to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 ConferenceBusiness Wire • 08/04/22
Personalis, Inc. (PSNL) CEO John West on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/04/22
Personalis Announces Expansion of Its Patent Portfolio Related to Tumor-Informed Detection of Molecular Residual DiseaseBusiness Wire • 07/12/22
Personalis, Inc.'s (PSNL) CEO John West on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/05/22
Evaxion to Utilize Personalis' ImmunoID NeXT Platform® to Evaluate Efficacy of Combination Therapy for Late-Stage MelanomaBusiness Wire • 04/26/22
Personalis Expands Diagnostic Leadership Team With Appointment of James Azzaro, Vice President of Diagnostic SalesBusiness Wire • 04/21/22
Personalis Publishes New Data Demonstrating Highly Sensitive Algorithm for Detecting Loss of Heterozygosity in HLA GeneBusiness Wire • 04/12/22
Personalis Announces Issuance of Additional US Patent Related to the NeXT Personal™ PlatformBusiness Wire • 04/12/22
Personalis and Merck KGaA, Darmstadt, Germany to Present Comprehensive Tumor Subtyping Collaboration Data at AACR Annual Meeting 2022Business Wire • 04/11/22
Personalis to Present at the 21st Annual Needham Virtual Healthcare ConferenceBusiness Wire • 03/31/22
Diagnostic Industry Veteran Karin Eastham to Chair Personalis Board of DirectorsBusiness Wire • 03/24/22
Personalis to Present Data Demonstrating Breadth of NeXT Platform for Oncology at AACR Annual Meeting 2022Business Wire • 03/23/22
Personalis Inc's (PSNL) CEO John West on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/25/22